Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04047121 · ClinicalTrials.gov registry record
A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients
A clinical trial, sponsored by Pfizer.
- Completed
- Registry status
- 1,349
- Enrollment target
NCT04047121 is a clinical trial that has completed, run by Pfizer. The registered enrollment target is 1,349 participants.
The verdict
NCT04047121 has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- 1,349 participants
- Enrollment target
Study Summary
This is a retrospective cohort study to evaluate patient characteristics, treatment patterns including a 6-factor effectiveness proxy measure, health care resource use and associated costs among Rheumatoid Arthritis patients initiating treatment comparator groups of interest between January 2014 and September 2016 across three United States insurance claims databases.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,349 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2019-10-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04047121
The ClinicalTrials.gov registry entry for NCT04047121 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,349 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04047121 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04047121 about?
NCT04047121 is a clinical study titled "A Study to Evaluate Patient Characteristics and Treatment Patterns Among Rheumatoid Arthritis Patients". This is a retrospective cohort study to evaluate patient characteristics, treatment patterns including a 6-factor effectiveness proxy measure, health care resource use and associated costs among Rheumatoid Arthritis patients initiating treatment comparator groups of interest between January 2014 and...
What is the current status of trial NCT04047121?
This trial is currently completed. The enrollment target is 1,349 participants. The study started on 2019-05-20. Estimated completion is 2019-10-21.
Who is sponsoring clinical trial NCT04047121?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.